Medical Mycology

Papers
(The median citation count of Medical Mycology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
P041 Preliminary evaluation of gradient concentration strips for detection of terbinafine resistance in Trichophyton spp.33
Effective detection of azole resistance in Aspergillus fumigatus sensu stricto using a gradient diffusion plastic strip: A comparison of filtered-adjusted vs. unfiltered-unadjusted inocula26
Correction to: Oral Presentations26
Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: An ultrastructural study25
Histoplasmosis screening using urinary antigen detection in people living with HIV in Southern Brazil25
S3.4a The repurposing approach identifies pitavastatin (calcium) making fluconazole fungicidal by inhibiting ergosterol synthesis24
Correction to: The high diversity of Scedosporium and Lomentospora species and their prevalence in human-disturbed areas in Taiwan23
P025 A study on candiduria in neonates and infants from a tertiary care center, North India.23
S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis22
COP27 Climate Change Conference: Urgent action needed for Africa and the world21
P133 Post-COVID-19 recurrent fungal urinary tract infections: A case series19
S4.2d Efficacy of LD Bio Aspergillus ICT lateral flow assay for serodiagnosis of chronic pulmonary aspergillosis18
P011 Antifungal lock therapy18
P482 Burden of serious fungal infections in India18
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis18
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis17
P337 Species distribution and biofilm profile of Candida isolated from clinical specimens at a tertiary care hospital in India17
S6.5d Molecular identification of mycetoma causative agents from patients in ahospital setting in Senegal17
P332 Evaluation of the efficacy of fumigation practices on the mycological flora in the Orthopedic Operation theatre environment of a tertiary care hospital16
P342 Lactobacillus rhamnosus protection against Candida-induced vaginal epithelial cell damage is Candida albicans strain-dependent16
P467 Aspergillosis in Humboldt penguins — susceptibility patterns of clinical and environmental isolates from a Belgian zoo, 2018-202216
P210 Fungal isolates of the respiratory tract in symptomatic patients hospitalized in pulmonary units: A mycological and molecular epidemiologic study15
P458 Comparison of PCR protocols for detecting Histoplasma capsulatum and Coccidioides spp. DNA through a multicenter study15
P328 An overexpression screen identifies Csa25 as a novel cellular morphogenesis regulator in the human fungal pathogen Candida albicans14
S9.4d Main reservoirs of Trichophyton mentagrophytes Type V in Iran14
P235 Rhino sinusoidal Lasiodiplodia theobromae: a clinical and diagnostic dilemma13
P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis13
P125 Histoplasma capsulatum modulates the immune response exerted by mesenchymal stromal cells13
P297 Disseminated histoplasmosis from skin to adrenals a cosmetic catastrophe—a rare case report13
S9.2d Directed evolution of voriconazole resistance in Aspergillus fumigatus identifies novel mutations responsible for triazole resistance12
S2.5a Magnusiomyces spp.12
P196 A rare presentation of subcutaneous Entomophthoramycosis12
P154 Fungal spore count in a tertiary care hospital in Mumbai, India11
P410 Aspergillus fumigatus sensitization among the patients with chronic obstructive pulmonary disease (COPD)— a cross sectional study11
P465 Aspergillosis in free-ranging Magellanic penguins11
P216 Rare isolates from subcutaneous mycotic lesions; A study from tertiary care center in Chhattisgarh, India11
S1.5a Epidemiology of myotic keratitis in developing countries11
P143 Incidence of chronic pulmonary aspergillosis in a cohort of bacteriologically confirmed TB patients at a tertiary hospital in Ghana11
P314 Atypical clinical manifestations and epidemiology of favus in southeast China in the last 15 years and a review of case studies10
P149 Short tandem repeat genotyping of South American Candida tropicalis isolates10
P243 Case series of Cryptococcal Meningitis—Experience in North Western India over 1 year (2021–22)10
P222 Epidemiology of Candida emia at level-1 trauma care cent er in North India10
P282 Bacterial co-infections in Mucormycosis infected COVID-19 patients: experience from a tertiary care center in India10
P237 Molecular epidemiology of Cryptococcosis—over 14 years using Whole Genome Sequencing and Multi-Locus Sequence Typing10
P246 Neglected keratitis caused by Exserohilum rostratum from the arid region of north-west India leading to vision loss—a case report10
P244 Catheter-associated blood stream infections due to Wickerhamiella pararugosa in a patient with acute myeloid leukemia: Review of lit eratures10
P232 Disseminated cryptococcosis in HIV due to different species — dissimilar yet alike!9
S9.4c Diverse environmental inputs mediate changes in β-glucan exposure at the Candida albicans cell surface thereby influencing tissue colonisation during systemic infection9
P326 DNA replication initiator proteins stabilize the kinetochore in the human fungal pathogen Cryptococcus neoformans9
P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report9
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival9
P269 Managing prosthetic valve endocarditis due to Sarocladium kiliense: Finding a way through uncertainties9
S10.5a Fungal respiratory infections in cystic fibrosis patients in the Middle East9
P331 A screen to identify the regulators of genome stability in the human commensal Candida albicans9
P115 Reversed-phase high-performance liquid chromatography as rapid and simple method for quantifications of terbinafine drug in human serum from dermatophytosis cases8
P251 Disseminated Histoplasmosis in a Ghanaian HIV Patient: Role of Urine Histoplasma Antigen Testing in Rapid Diagnosis8
P361 Demystifying the NIH grant application process for international investigators8
P378 Insecticidal potential of isolated fungal species in targeting Drosophila melanogaster and Zaprionus indianus8
P266 A case of mixed fungal infection causing invasive fungal Rhinosinusitis in a post-COVID patient8
P208 Genetic diversity of the emerging human fungal pathogen Pichia norvegensis8
P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples8
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?8
P156 Oral Candidiasis among inpatients with COVID-19 in the North of Iran8
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain8
P434 Anti fungal susceptibility of Malassezia to azoles by broth microdilution method and their phylogenetic relationship based on multi-locus sequence analysis8
P245 Arthrinium species, a filamentous ascomycetes isolated from samples of human cutaneous infections-report from a medical mycology laboratory of Assam, North-East India7
P440 General protocol applied to the identification and production of new biomarkers with potential use for the diagnosis of histoplasmosis7
S10.5d Disseminated pulmonary infection due to Mortierella wolfii in a 6-year-old patient with X-linked CGD receiving MUD-HSCT7
P445 Clinical evaluation of the performance of the most commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the golden standard7
P383 ‘It's not Fungus, its Nocardia’—an elementary diagnostic challenge for draining sinus on abdominal wall (rare): a case report7
P290 Public health treatment due to rise in Candida auris candidemia infection7
S5.1b Antifungal r esistance7
P371 The relation of mating type (MAT) preference and source in the opportunistic pathogen Talaromyces marneffei7
P357 Update on risk factors for Candida krusei-Fungemia7
P417 Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-Bruker Biotyper Sirius for identification of invasive molds7
P063 Research on antifungal activity of a new azoles compound, YZJT-19037
S1.3c Diversity and hybridization in Malassezia furfur7
S1.3a Genetics andgenomics of Malassezia species7
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management7
P034 Non-conventional alternatives to prevent Candida auris infections6
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study6
Correction to: S8.5c MLST genotyping and phylogenetics of AD-hybrids6
P370 Low rate of Sporothrix spp. recovery from storage in mineral oil: along period study6
P444 Detection of causative agents of infectious keratitis in patients from western rajasthan6
P067 Cumulative hospital antibiogram of AIIMS Bhopal for Candida species6
P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex6
P075 Initial results of an international effort in screening new agents against Candida auris6
Correction to: NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile6
P436 A study to compare detection of Aspergillus galactomannan in patients with clinically suspected invasive Aspergillosis using the Lateral Flow Assay (LFA) in comparison with Enzyme Linked I6
P416 Efficient and accurate diagnosis of otomycosis using an ensemble deep learning model6
P047 Comparative evaluation of disc diffusion and E-test with broth micro-dilution in susceptibility testing of amphotericin B, posaconazole, isuvuconazole, itraconazole against Rhizopus isolat6
P083 Susceptibility pattern of fungal isolated from patients with otomycosis6
P002 Antifungal activity of antimicrobial synthetic peptides against Candida species of public health importance6
P031 Post-antifungal effect of the combination of a nidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and resistant Candida albicans6
P424 Comparative analysis of Galactomannan Lateral Flow Assay, Galactomannan Enzyme Immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis6
P015 A study to demonstrate heteroresistance and tolerance to azoles in Candida tropicalis6
High histoplasmosis incidence in kidney transplant recipients in Santa Fe city, Argentina5
Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis5
Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients5
In vitro and in vivo efficacies of Dectin-1-Fc(IgG)(s) fusion proteins against invasive fungal infections5
Evaluation of formic acid sandwich (FA-sandwich): A pretreatment method for filamentous fungi, for the identification of clinically relevant filamentous fungi by two MALDI-TOF MS systems5
Disposition of posaconazole after single oral administration in large falcons (Falco spp): Effect of meal and dosage and a non-compartmental model to predict effective dosage5
Molecular epidemiology and antifungal susceptibility of dermatophytes and Candida isolates in superficial fungal infections at a grade A tertiary hospital in Northern China5
Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort5
P213 Lasiodiplodia theobromae: an emerging human pathogen5
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India5
Nosocomial transmission ofAspergillus flavusin a neonatal intensive care unit: Long-term persistence in environment and interest of MALDI–ToF mass-spectrometry coupled with convolutional neural5
Distribution and genotypic analysis of Enterocytozoon bieneusi from wild boars in Korea5
Effect of copper on the antifungal activity of disulfiram (Antabuse®) in fluconazole-resistant Candida strains5
Fungal yield from sterile specimens5
Opportunistic yeast pathogenCandidaspp.: Secreted and membrane-bound virulence factors5
Inhibitory effect of polyunsaturated fatty acids alone or in combination with fluconazole on Candida krusei biofilms in vitro and in Caenorhabditis elegans5
Malassezia gallinae sp. nov., a new basidiomycetous yeast species isolated from skins of chickens5
Molecular epidemiology of Candida africana isolates collected from vagina swabs in French Guiana5
P306 Scedosporium spp. and Lomentospora prolificans, fungal agents with unexpected vascular tropism5
P217 Pelvic mycoses— an unusual presentation of Rhizopus arrhizus in an ommunocompetent patient5
Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018–2022): An observational study5
Fusarium spp. causing invasive disease in humans: A case series from north India5
Intestinal mycobiome associated with diagnosis of inflammatory bowel disease based on tissue biopsies5
Madurella mycetomatis grains within a eumycetoma lesion are clonal5
Evaluation of overtime phenotypic variation of yeasts in chronic vulvovaginal candidosis cases5
A novel model for predicting deep-seated candidiasis due to Candida glabrata among cancer patients: A 6-year study in a cancer center of China5
Segmentation of hyphae and yeast in fungi-infected tissue slice images and its application in analyzing antifungal blue light therapy5
S2.3d Mixed biofilm of Aspergillus fumigatus and Stenotrophomonas maltophilia: Microscopic visualization of galactosaminogalactan and galactomannan polysaccharides in the extracellular m5
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?4
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo4
S5.3b Fungal spores: Initiators of colonization and infection4
Parietal composition of Lichtheimia corymbifera: Differences between spore and germ tube stages and host-pathogen interactions4
Aspergillosis in a colony of Humboldt penguins (Spheniscus humboldti) under managed care: a clinical and environmental investigation in a French zoological park4
The high diversity of Scedosporium and Lomentospora species and their prevalence in human-disturbed areas in Taiwan4
Bibliometric analysis and thematic review of Candida pathogenesis: Fundamental omics to applications as potential antifungal drugs and vaccines4
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants4
Cryptococcosis in Africa: What the data tell us4
Outcome of patients with cystic fibrosis colonized byScedosporiumandLomentosporaspecies: A longitudinal cohort study4
Gastrointestinal tract Candida spp colonization shows mostly a monoclonal pattern: an intra-patient pilot study4
Tremellomycetes isolated from organs of Columba livia4
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis4
A Falciformispora senegalensis grain model in Galleria mellonella larvae4
FertileCryptococcus neoformansvar.neoformans(C. deneoformans) isolates from natural environment in Kosovo4
Covid-19-associated fungal osteomyelitis of jaws and sinuses: An experience-driven management protocol4
COVID-19-associated pulmonary aspergillosis in a tertiary care center in the Midwestern Region of Brazil4
P056 Oral Ibrexafungerp outcomes by fungal disease in patients from an interim analysis of a Phase 3 Open-label Study (FURI)4
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa4
The Billirud Mill Blastomycosis Outbreak: Comparison to Historical Controls4
Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis4
A systematic review on distribution and antifungal resistance pattern ofCandidaspecies in the Indian population4
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis4
AfSec1 is a signal peptidase and removes signal peptides of 1,3-β-glucanosyltransferases in Aspergillus fumigatus4
Activation of cytokine responses by Candida africana4
Metabolic and morphostructural plasticity of environmental and animal strains of Nannizzia gypsea4
Triazole resistance in Aspergillus fumigatus isolates in Africa: a systematic review4
Molecular characterization of fungal endophthalmitis and keratitis caused by yeasts4
A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole4
Multicentric prospective evaluation of Pneumocystis jirovecii fungal load in bronchoalveolar lavage fluid fractions using qPCR4
Talaromyces marneffei, Coccidioides species, and Paracoccidioides species—a systematic review to inform the World Health Organization priority list of fungal pathogens4
Isolation of a fungal calcineurin A mutant suggests that amoebae can counter-select virulence attributes of microbes4
Materials used to prevent adhesion, growth, and biofilm formation ofCandidaspecies4
Gut mycobiota changes in liver diseases: A systematic review4
P350 Oropharyngeal candidiasis in HIV infected patients: associated risk factors and antifungal susceptibility testing of candida species by disc diffusion method4
Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis4
Molecular epidemiology of clinical filamentous fungi in Qatar beyond Aspergillus and Fusarium with notes on the rare species4
In depth search of the Sequence Read Archive database reveals global distribution of the emerging pathogenic fungus Scedosporium aurantiacum4
Knowledge and regulation on fungal contamination of sand and water: Progress report and perspectives3
P177 A Psittacine bite and subcutaneous Zygomycosis in immune competent: Case with therapeutic challenge3
P137 Remote inoculation mycosis: Rip Van Winkle wakes up3
Secreted factors of Aspergillus fumigatus cause lung epithelial barrier disruption: A study using an air–liquid interface cell culture model3
P293 Development of a multiplex PCR short tandem repeat typing scheme for Candida tropicalis3
P413 Screening and diagnosis of Candidemia in adult hematological malignancies of northern India3
Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortality3
P408 Evaluation of fungal serum biomarkers in the diagnosis and for monitoring patients with post tuberculosis chronic pulmonary aspergillosis3
P138 A decade of cat-transmitted sporotrichosis (CTS) in a tertiary hospital from Curitiba, southern Brazil (2011-21)3
S1.3d The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation3
S10.3c Clinical studies provide new insights on the association between the microbiota and host resistance to Candida albicans intestinal colonization3
Correction to: Neutrophil extracellular traps (NETs) and Th-2 dominant immune responses in chronic granulomatous chromoblastomycosis3
P240 Candida nivariensis infection in South East Asia: series of case reports from Selayang Hospital, Malaysia and South East Asia Region3
P195 Factors related to outcome of bloodstream infections due to Candida parapsilosis complex: A single center observation study from Central India3
Assessment of panfungal PCR performance with formalin-fixed paraffin-embedded tissue specimens3
P148 Emerging and cryptic Aspergillus species isolated from hospitalized patients with underlying primary immunodeficiencies3
The Argentinian landscape of mycological diagnostic capacity and treatment accessibility3
P197 Infant-juvenile paracoccidioidomycosis. Two Argentine endemic zones with different epidemiological and clinical aspects? What influences this situation?3
S3.4e Unraveling the role of DOG genes in a novel alternative pathway of glycerol biosynthesis in Candida albicans and its influence on virulence3
Natural history of pulmonary coccidioidomycosis: Further examination of the VA-Armed Forces Database3
P152 African Woman With a Knee Knocked by a Rare Dematiaceous Fungi3
Human activity, not environmental factors, drives Scedosporium and Lomentospora distribution in Taiwan3
P167 Fungemia in neonatal ICU of a pediatric hospital in NE India3
P488 Successful treatment of breakthrough invasive aspergillosis in an immunocompetent individual based on therapeutic drug monitoring: A case report3
S10.4c Successful treatment of mucormycosis in hematological diseases3
P150 Profile of Candidemia in a national level HAI Surveillance Network of India3
Detection of circulating DNA for the diagnosis of invasive fusariosis: retrospective analysis of 15 proven cases3
P106 A dermoscopic finding of Tinea capitis caused by Microsporum canis3
OUP accepted manuscript3
P258 Incidence of Histoplasmosis, Cryptococcosis, and TB Among People Living with HIV in Paraguay-Preliminary Report3
P281 Healthy adult with arm swelling and new onset burning pain3
Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina3
P155 A Mexican case series of COVID-19 - associated pulmonary aspergillosis3
S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: Role in pathogenicity3
P192 Investigating the link between pleomorphism and virulence in Cryptococcus3
P456 Defungi: direct mycological examination of microscopic fungi images3
P382 Scalp fungal microbiome and sebum composition in males with and without androgenetic alopecia2
P088 Molecular identification and antifungal susceptibility of pathogenic yeasts from the China Antifungal Resistance Surveillance Trial (CARST-fungi) Study2
P094 Atypical cutaneous manifestations of sporotrichosis in Brazil2
P490 Fatal secondary fungemia due to Trichosporon asahii onychomycosis in a diabetic patient2
P051 A case of recalcitrant sporotrichosis by infection of Sporothrix globosa2
S5.5d SARS-CoV-2 associated invasive fungal sinus infections; the Sri Lankan perspective2
P006 Resistance of Aspergillus flavus clinical isolates and associated fitness-cost2
P277 The epidemiology, clinical manifestations and outcomes of cerebral mucormycosis: A systematic review2
P007 Fumaric reductase analog regulates sensitivity of pyrvinium pamoate and voriconazoole against Exophiala Dermatiti dis2
P268 Laryngeal Mucormycosis: does mucor take the voice away?2
S5.3c Investigating the link between pleomorphism and virulence in Cryptococcus2
P212 Fatal invasive aspergillosis in a child with Chronic Granulomatous disease; a case report2
P426 Interleukins—a non-invasive biomarker for invasive fungal sinusitis2
P174 Prevalence and outcomes of patients with COVID - associated mucormycosis (CAM): A case series2
S2.2a African histoplasmosis2
S10.5c Insight into the role of secondary metabolism in the pathogenesis of Scedosporium apiospermum2
P093 A novel GAL4-like transcriptional regulator modulate the azoles sensitivity of Exophiala dermatitidis2
P427 The value of nasal and oral clinical examination in febrile neutropenic patients for initiating anti-fungal therapy as a preemptive method2
P504 Screening of Belgian bats and hibernacula for the description of related fungal microbiomes and the detection of Pseudogymnoascus destructans2
P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India2
P048 Antifungal susceptibility and mechanism of azole resistance in Candida albicans clinical isolates from oropharyngeal candidiasis patients in Iran2
S4.5d Comparing the diagnostic performance of the commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the gold standard2
P044 Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris2
P325 Trend of cryptococcal meningitis in patients attending a teaching hospital in north-east india — a single center study2
P033 Genomic epidemiology of the antifungal-resistant dermatophytosis epidemic, India, 2017-20192
P253 Features of Cryptococcosis in human immunodeficiency virus-negative patients, France 1985-20202
P001 Characteristics and dynamics of azole-resistant Aspergillus fumigatus variants emerging over a 28-year period in the Netherlands2
P271 A masquerading case of Cryptococcus neoformans2
S5.3a Unraveling the genetic determinants of virulence in Cryptococcus neoformans2
P162 Parinaud's Oculoglandular Syndrome as an atypical manifestation of sporotrichosis in Brazil2
S6.2b In vitro susceptibility testing of dermatophytes: toward standardization2
S7.3d Environmental surveillance of Aspergillus fumigatus in Dutch agricultural crops2
P400 A study of the ecology, evolution and resistance mechanism of Candida auris at a tertiary care center in North India2
P010 Evaluation of antifungal efficacy of two novel cyclic lipopeptides of the class Bacillomycin from Bacillus subtilis RLID 12.1 in a murine model of invasive candidiasis2
P492 Invasive fungal infection during COVID era at tertiary care hospital2
S5.4b Genomic variation structure in clinical isolate collections alters benefits of association screening: a study of Cryptococcus neoformans var. grubii in Colombia2
P463 Toxicological evaluation of Aureobasidum pullulans var. pullulans induced mycotoxicosis in amurine model2
P092 Otilonium bromide is a potent antifungal agent against fluconazole- and flucytosine-resistant Cryptococcus neoformans strains2
P030 Highly slow-release antifungal wound dressing for chronic dermatophytosis2
P437 Diagnostic utility of serum beta D glucan test to prescribe antifungal treatment and its effect on patient's outcome: a study from a tertiary care center in Western India2
P013 Green synthesis of silver nanoparticles using Trillium govanianum and its antifungal potential against Candida auris2
P466 Isolation of Cryptococcus neoformans and other yeast from pigeon droppings in Khartoum state, Sudan2
P076 The promising antimycotic activities of a novel cyclic antifungal lipopeptide against Human Dermatophyte Isolates2
P478 Identification of clinical Candida isolates using maldi-tof-ms and their antifungal susceptibility profile—a study from tertiary care pediatric hospital in noida2
P054 Two effects of curcumin to Candida albicans2
P219 Fungal keratitis caused by Pseudallescheria boydii: Clinical and mycological characteristics2
P355 Pitfalls in medical mycology in India2
P309 Clonal outbreak of Trichophyton tonsurans causing tinea capitis among wrestlers in Beijing, China2
P365 Upsurge of Mucormycosis in COVID-19—a retrospective study in a tertiary care hospital in Punjab2
S3.2 Challenging clinical cases2
P442 Bacterial and fungal infection in COVID-19 diagnosed cases in a tertiary care ICU setting in the wake of second wave in Kolkata, India2
P014 Prevalence and antifungal susceptibility of Wickerhamomyces anomalus in a tertiary care center2
0.22215485572815